Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist PotencyGustave Adouvi, Daniel Merk, Silvia Arifi et al.|Journal of Medicinal Chemistry|2023Cited by 10
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 AgonismSabine Willems, Daniel Merk, Romy Busch et al.|Journal of Medicinal Chemistry|2024Cited by 6
Structural optimization of oxaprozin for selective inverse Nurr1 agonismSabine Willems, Daniel Merk, Romy Busch et al.|ChemRxiv|2024Cited by 1